{
      "ptx_code": "PTX134",
      "chem_name": "Prochloraz",
      "casrn": "67747-09-5",
      "dtxsid": "DTXSID4024270",
      "smiles": "CCCN(CCOC1=C(Cl)C=C(Cl)C=C1Cl)C(=O)N1C=CN=C1",
      "inchikey": "TVLSRXXIMLFWEO-UHFFFAOYSA-N",
      "label": "PTX134 | Prochloraz",
      "drugbank_id": "",
      "use_class": "Pesticide",
      "tox_class": "Hematotoxicity; Ototoxicity; Hepatotoxicity; Neurotoxicity; Genotoxicity; Nephrotoxicity; Cardiotoxicity",
      "chem_name_user": "Prochloraz",
      "mw_g_mol": "376.66",
      "solubility_h2o_mol_liter": "8.33735e-05",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "1.92882e-07",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "5.10301797122576",
      "source_kaw": "LSER",
      "pka_acid": "",
      "pka_base": "5.66",
      "source_pka": "ACD pKa/GALAS",
      "log_kow_liter_liter": "4.1",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "4.25328566885276",
      "source_dlipw": "Kow-QSAR (\u00e2\u02c6\u2020mw=1)",
      "freely_dissolved_fraction": "0.114879198883148",
      "density_kg_liter": "",
      "source_density": "COMPTOX",
      "baseline_drerio": "10.2152073828185",
      "baseline_dmagna": "11.1658984080978",
      "baseline_celegans": "24.7892347582222",
      "baseline_xlaevis": "19.5646931992745",
      "baseline_dmelanogaster": "94.2900717103305",
      "baseline_cells": "1.24147225829798e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "1.42619338468924e-06",
      "moa_drugbank": "",
      "protein_binding": "",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 18,
                  "AOP_name": "PPAR\u03b1 activation in utero leading to impaired fertility in males "
            },
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 36,
                  "AOP_name": "Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis "
            },
            {
                  "AOP_id": 57,
                  "AOP_name": "AhR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 131,
                  "AOP_name": "Aryl hydrocarbon receptor activation leading to uroporphyria "
            }
      ],
      "targets": [
            "25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",
            "ATP-binding cassette sub-family G member 2",
            "Androgen receptor",
            "Aryl hydrocarbon receptor",
            "Bile acid receptor",
            "Bile salt sulfotransferase",
            "Bone morphogenetic protein receptor type-2",
            "C-C motif chemokine 2",
            "Cyclic AMP-responsive element-binding protein 3",
            "Cytochrome P450 19A1",
            "Cytochrome P450 1A1",
            "Cytochrome P450 1A2",
            "Cytochrome P450 2B6",
            "Cytochrome P450 2C18",
            "Cytochrome P450 2C19",
            "Cytochrome P450 2C8",
            "Cytochrome P450 2C9",
            "Cytochrome P450 2D6",
            "Cytochrome P450 2J2",
            "Cytochrome P450 3A5",
            "Estrogen receptor alpha",
            "Matrix metalloproteinase-9",
            "Multidrug resistance protein 1",
            "Nuclear factor erythroid 2-related factor 2",
            "Nuclear receptor subfamily 1 group I member 2",
            "Peroxisome proliferator-activated receptor gamma",
            "Prostaglandin E2 receptor EP2 subtype",
            "Retinoic acid receptor alpha",
            "Retinoic acid receptor gamma-2",
            "Sodium-dependent dopamine transporter",
            "Sodium-dependent noradrenaline transporter",
            "Sodium-dependent serotonin transporter",
            "Translocator protein",
            "Tumor necrosis factor",
            "Tumor necrosis factor receptor superfamily member 10B",
            "cAMP-specific 3',5'-cyclic phosphodiesterase 4A"
      ]
}